More recently, we have identified a synthetic small molecule NFAT1 and MDM2 inhibitor, termed MA242, which has been shown to inhibit tumor growth in in vitro and in vivo models of pancreatic cancer and HCC [36,37]. Here, MDM2 is linked to pancreatic neoplasm.